Related Experiment Video
Updated: Jul 3, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Daptomycin, a lipopeptide antibiotic in clinical practice
Florian Weis1, Andres Beiras-Fernandez, Gustav Schelling
1Department of Anesthesiology, University Hospital Grosshader, Marchioninistrasse 15, 81377 Munich, Germany. Florian.Weis@med.uni-muenchen.de
Current Opinion in Investigational Drugs (London, England : 2000)
|July 31, 2008
Summary
New lipopeptide antibiotic daptomycin shows promise for treating multidrug-resistant Gram-positive cocci infections, including Methicillin-resistant Staphylococcus aureus (MRSA). Its efficacy and safety profile suggest potential for expanded clinical use beyond current FDA approvals.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Gram-positive cocci are a primary cause of clinical infections.
- Multidrug resistance, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a significant treatment challenge.
- Vancomycin, a common treatment, has notable nephro- and ototoxicity side effects.
Purpose of the Study:
- To provide an overview of the antibiotic daptomycin.
- To highlight daptomycin's potential for new indications in treating resistant infections.
Main Methods:
- Literature review of daptomycin's properties and clinical applications.
- Analysis of current and potential future uses of daptomycin.
Main Results:
- Daptomycin is a lipopeptide antibiotic effective against Gram-positive cocci.
- It is approved for complicated skin infections and endocarditis.
- Its pharmacological profile supports exploring new therapeutic uses.
Conclusions:
- Daptomycin represents a valuable therapeutic option against multidrug-resistant Gram-positive cocci.
- Further research into new indications for daptomycin is warranted.
- Daptomycin may offer an alternative to vancomycin with a different safety profile.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).